Dianthus Therapeutics (DNTH) Preferred Dividend Payments (2017 - 2018)
Dianthus Therapeutics (DNTH) recorded quarterly Preferred Dividend Payments of $88000.0 in Q2 2018, down 60.71% quarter-over-quarter from $224000.0 in Q4 2017, and down 57.49% on a YoY basis from $207000.0 in Q2 2017.
Dianthus Therapeutics (DNTH) Preferred Dividend Payments (2017 - 2018) Analysis & Trends
Dianthus Therapeutics' Preferred Dividend Payments history runs 2 years deep, the most recent figure standing at $88000.0 for Q2 2018.
- In Q2 2018, Preferred Dividend Payments fell 57.49% year-over-year to $88000.0; the TTM figure through Dec 2018 stood at $312000.0 (changed N/A YoY), while the FY2018 annual figure was $88000.0, down 79.86% from the prior year.
- Preferred Dividend Payments was $88000.0 for Q2 2018 at Dianthus Therapeutics, down from $224000.0 in the prior quarter.
- In the past five years, Preferred Dividend Payments ranged from a high of $224000.0 in Q4 2017 to a low of $6000.0 in Q3 2017.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Pref Dividends (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Dianthus Therapeutics | 3.60 Bn | 3.19 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2018 | 88,000.00 |
| Dec 31, 2017 | 224,000.00 |
| Sep 30, 2017 | 6,000.00 |
| Jun 30, 2017 | 207,000.00 |